Correlation Between ASTELLAS PHARMA and Bayer AG

Can any of the company-specific risk be diversified away by investing in both ASTELLAS PHARMA and Bayer AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ASTELLAS PHARMA and Bayer AG into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ASTELLAS PHARMA UNSPADR and Bayer AG NA, you can compare the effects of market volatilities on ASTELLAS PHARMA and Bayer AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ASTELLAS PHARMA with a short position of Bayer AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of ASTELLAS PHARMA and Bayer AG.

Diversification Opportunities for ASTELLAS PHARMA and Bayer AG

0.81

Correlation Coefficient

ASTELLAS PHARMA  Bayer AG

Very poor diversification

The 3 months correlation between ASTELLAS and Bayer is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding ASTELLAS PHARMA UNSPADR and Bayer AG NA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bayer AG NA and ASTELLAS PHARMA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ASTELLAS PHARMA UNSPADR are associated (or correlated) with Bayer AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bayer AG NA has no effect on the direction of ASTELLAS PHARMA i.e., ASTELLAS PHARMA and Bayer AG go up and down completely randomly.

Pair Corralation between ASTELLAS PHARMA and Bayer AG

Assuming the 90 days trading horizon ASTELLAS PHARMA UNSPADR is expected to generate 0.92 times more return on investment than Bayer AG. However, ASTELLAS PHARMA UNSPADR is 1.09 times less risky than Bayer AG. It trades about -0.03 of its potential returns per unit of risk. Bayer AG NA is currently generating about -0.11 per unit of risk. If you would invest  1,292  in ASTELLAS PHARMA UNSPADR on September 12, 2024 and sell it today you would lose (337.00) from holding ASTELLAS PHARMA UNSPADR or give up 26.08% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	99.7%
Values	Daily Returns

ASTELLAS PHARMA UNSPADR  vs.  Bayer AG NA

ASTELLAS PHARMA UNSPADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ASTELLAS PHARMA UNSPADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Bayer AG NA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bayer AG NA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with ASTELLAS PHARMA and Bayer AG

The main advantage of trading using opposite ASTELLAS PHARMA and Bayer AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ASTELLAS PHARMA position performs unexpectedly, Bayer AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bayer AG will offset losses from the drop in Bayer AG's long position.

The idea behind ASTELLAS PHARMA UNSPADR and Bayer AG NA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.